Inositolic Combi Capsules – PCOS & Fertility Support

Category: PCOS, Hormonal Balance & Female Fertility Supplement | Form: Oral Capsule | Pack Size: 30 Capsules | Manufacturer: Galaxy Pharma | Status: Dietary Supplement — DRAP Registered

What is Inositolic Combi?

Inositolic Combi is a scientifically formulated women's health supplement by Galaxy Pharma — combining Myo-Inositol 1100mg, D-Chiro-Inositol 27.6mg, and Folic Acid 400mcg in the clinically researched 40:1 ratio of Myo-Inositol to D-Chiro-Inositol that mirrors the physiological ratio found in healthy human plasma. This specific ratio is not arbitrary — it represents the optimal balance between the two inositol isomers as established by clinical research into PCOS pathophysiology and inositol supplementation outcomes. Polycystic Ovary Syndrome (PCOS / پی سی او ایس) is the most common endocrine disorder in women of reproductive age — affecting 8 to 13% of women globally and representing the leading cause of anovulatory infertility. At its metabolic core, PCOS is characterised by insulin resistance and inositol deficiency in ovarian tissue — both of which disrupt the insulin signalling cascade that governs follicular development, ovarian hormone production, and oocyte quality. Inositolic Combi directly addresses this metabolic root cause — restoring intracellular insulin signalling in ovarian granulosa cells, reducing hyperinsulinaemia, normalising androgen production, supporting regular ovulation, and improving egg quality — while Folic Acid provides essential nutritional support for DNA synthesis and reproductive health. This makes Inositolic Combi one of the most evidence-supported nutritional interventions available for PCOS management alongside lifestyle modification and medical treatment.

What is Inositolic Combi Used For?

• Polycystic Ovary Syndrome (PCOS) — restoring insulin sensitivity and hormonal balance in women with PCOS to improve ovarian function, reduce androgens, and support regular menstruation (پی سی او ایس میں ہارمون کا توازن)
• Insulin resistance — improving cellular insulin sensitivity and reducing the hyperinsulinaemia that drives androgen excess in PCOS (انسولین کی مزاحمت)
• Irregular or absent menstruation — supporting regular menstrual cycle restoration through improved ovarian hormonal signalling and follicular development (ماہواری کی بے قاعدگی)
• Anovulation and infertility — promoting regular ovulation in women with PCOS-related anovulatory infertility to support natural conception (بانجھ پن)
• Oocyte quality improvement — nutritional support for better egg quality and fertilisation potential — particularly relevant for women undergoing IVF or assisted reproduction
• Hirsutism and acne — reducing excess androgen levels to improve unwanted facial and body hair and hormonal acne (چہرے کے غیر ضروری بال اور مہاسے)
• Metabolic syndrome — supporting healthy insulin sensitivity, blood sugar regulation, and lipid metabolism in women with PCOS-related metabolic syndrome
• Pre-conception nutritional support — Folic Acid 400mcg providing the recommended pre-conception dose for neural tube defect prevention before and during early pregnancy (حمل سے پہلے فولک ایسڈ)
• Ovarian stimulation support — nutritional preparation for ovulation induction treatment or IVF cycles under reproductive specialist supervision

How Does Inositolic Combi Work?

The Inositol Deficiency Theory of PCOS:

Inositols are naturally occurring polyol compounds that serve as critical second messengers in the insulin signalling cascade inside cells. When insulin binds to its receptor on the cell surface, it triggers the release of inositolphosphoglycan (IPG) mediators — including Myo-Inositol-containing IPG (MYO-IPG) and D-Chiro-Inositol-containing IPG (DCI-IPG) — that transmit the insulin signal within the cell to activate glucose uptake and regulate downstream hormonal and metabolic processes. In PCOS, two distinct but related defects in inositol metabolism occur: first, a generalised reduction in cellular inositol availability due to impaired absorption and recycling — reducing the efficiency of insulin signal transmission; second, a specific tissue-level imbalance where the ovary — which normally maintains a high Myo-Inositol to D-Chiro-Inositol ratio — accumulates excess D-Chiro-Inositol at the expense of Myo-Inositol due to an overactive conversion enzyme (epimerase) driven by hyperinsulinaemia. This local DCI excess in ovarian granulosa cells paradoxically impairs follicular development and oocyte quality while the systemic inositol deficiency perpetuates insulin resistance.

Myo-Inositol 1100mg — Insulin Sensitiser and Oocyte Quality:

Myo-Inositol (MI) is the most abundant inositol isomer in human biology and the primary intracellular second messenger for insulin signalling in most tissues including the ovary. Supplementing Myo-Inositol at 1100mg restores adequate MI availability in ovarian granulosa cells — improving FSH (Follicle-Stimulating Hormone) receptor signalling, supporting healthy follicular development, enhancing oocyte nuclear and cytoplasmic maturation, and improving fertilisation rates and embryo quality. Myo-Inositol also restores insulin sensitivity in peripheral tissues — particularly muscle and adipose tissue — reducing the compensatory hyperinsulinaemia that drives the LH/FSH ratio dysregulation, excess androgen production, and anovulation of PCOS. Clinical studies of Myo-Inositol supplementation in PCOS have demonstrated improvements in menstrual cycle regularity, ovulation rate, oocyte quality, AMH levels, testosterone, and insulin sensitivity — making it the most clinically validated single nutritional intervention for PCOS.

D-Chiro-Inositol 27.6mg — Insulin Signal Amplification and Androgen Reduction:

D-Chiro-Inositol (DCI) is a less abundant inositol isomer that serves as the primary intracellular mediator of insulin's effect on androgen-producing pathways — specifically by activating pyruvate dehydrogenase (PDH) — an enzyme involved in glucose oxidation — and by modulating the enzyme systems that regulate androgen biosynthesis in ovarian theca cells. At 27.6mg — representing the 40:1 ratio with 1100mg Myo-Inositol — DCI provides the physiologically appropriate amount to amplify insulin signalling in androgen-producing pathways and reduce excess androgen synthesis in PCOS ovarian tissue without the paradoxical oocyte quality impairment seen with higher DCI doses. The critical clinical insight behind the 40:1 ratio is that DCI alone at higher doses worsens oocyte quality by reducing the Myo-Inositol concentration in follicular fluid below the threshold needed for oocyte maturation — whereas the 40:1 ratio provides adequate DCI for androgen reduction while preserving the Myo-Inositol predominance essential for oocyte quality.

The 40:1 Physiological Ratio — Why It Matters:

The Myo-Inositol to D-Chiro-Inositol ratio of 40:1 in Inositolic Combi is not an arbitrary commercial formulation choice — it directly reflects the physiological plasma ratio found in healthy women without PCOS. Multiple clinical studies comparing different MI:DCI ratios have demonstrated that the 40:1 ratio produces the optimal balance of outcomes: best improvements in oocyte quality and fertilisation, best menstrual cycle regularisation, best androgen reduction, and best insulin sensitivity — outperforming either isomer alone and outperforming other ratios. This evidence-based ratio is now the recommended standard in clinical guidelines for inositol supplementation in PCOS from European reproductive medicine societies.

Folic Acid 400mcg — DNA Synthesis and Pre-Conception Support:

Folic Acid is the synthetic form of folate — an essential B-vitamin for one-carbon metabolism, DNA synthesis, DNA repair, and methylation reactions throughout the body. In reproductive health, Folic Acid at 400mcg — the internationally recommended pre-conception dose — reduces the risk of neural tube defects (anencephaly and spina bifida) in early embryonic development by ensuring adequate folate availability during the critical period of neural tube closure in the first 28 days after conception — often before pregnancy is confirmed. Folic Acid also reduces sperm and oocyte DNA fragmentation, supports homocysteine metabolism — elevated homocysteine being an independent risk factor for pregnancy loss — and supports the healthy cell division required for follicular development and early embryogenesis. Including Folic Acid at the recommended pre-conception dose makes Inositolic Combi suitable as a complete pre-conception supplement for women with PCOS trying to conceive.

Dosage and Administration

Usage Guidelines:

• Standard dosing for PCOS management — 1 capsule twice daily (morning and evening) with meals — providing 2200mg Myo-Inositol, 55.2mg D-Chiro-Inositol, and 800mcg Folic Acid daily; consult your gynaecologist for your specific recommended dose
• Minimum supplementation period — consistent daily supplementation for a minimum of 3 months is required before meaningful improvements in menstrual cycle regularity, androgen levels, and oocyte quality can be assessed; hormonal and metabolic changes require time to develop
• For pre-conception use — begin supplementation at least 3 months before planned conception to benefit egg quality and ensure adequate Folic Acid levels during the critical early pregnancy period
• For IVF preparation — start at least 3 months before the planned stimulation cycle under reproductive specialist guidance
• Continue supplementation as advised by your gynaecologist or endocrinologist — do not stop and restart inconsistently as the metabolic benefits of inositol supplementation develop progressively with consistent daily use
• Inositolic Combi complements — but does not replace — lifestyle modification including weight management, low glycaemic index diet, and regular exercise which are the foundation of PCOS management

Active Ingredients Per Capsule

The 40:1 Myo-Inositol to D-Chiro-Inositol ratio mirrors healthy physiological plasma levels — clinically validated as the optimal ratio for PCOS management.

Who Should NOT Take Inositolic Combi?

Do not take if you:

• Are allergic to any ingredient in the capsule
• Have been diagnosed with kidney disease (گردے کی بیماری) — inositol is renally cleared; discuss with your nephrologist
• Are taking Metformin without informing your doctor — combined inositol and Metformin supplementation requires medical monitoring of blood sugar and potential dose adjustment

Always consult your gynaecologist or endocrinologist before taking Inositolic Combi if you:

• Have Type 1 or Type 2 Diabetes (ذیابیطس) — Myo-Inositol improves insulin sensitivity and may lower blood sugar; antidiabetic medicine doses may need adjustment
• Are taking insulin or sulphonylureas — hypoglycaemia risk increases with improved insulin sensitivity
• Are currently pregnant — Folic Acid 400mcg is safe and recommended in pregnancy; however confirm appropriate inositol dosing during pregnancy with your obstetrician
• Are taking hormonal contraceptives — discuss whether supplementation alongside contraceptives aligns with your health goals
• Have hypothyroidism — PCOS and thyroid disease frequently co-exist; inositol may affect thyroid function in some patients; monitor thyroid status
• Have bipolar disorder — Myo-Inositol at high doses has been associated with mood changes in bipolar patients; inform your psychiatrist
• Are undergoing fertility treatment — inform your reproductive specialist of all supplements being taken as they may adjust treatment protocols accordingly

Side Effects

Common and Generally Mild:

• Mild nausea or stomach discomfort — most common; significantly reduced by taking with food
• Mild diarrhoea or loose stools — particularly at higher doses; usually self-limiting and resolves within the first 1 to 2 weeks
• Mild bloating or flatulence — inositol fermentation in the gut; usually temporary
• Mild headache — usually temporary; typically resolves within the first week
• Dizziness — rare; usually associated with blood sugar lowering in diabetic patients on antidiabetic medicines

Monitor and Report to Your Doctor:

• Unexpectedly low blood sugar (hypoglycaemia) — in patients on insulin, sulphonylureas, or Metformin; shaking, sweating, dizziness, confusion — Myo-Inositol's insulin-sensitising effect may enhance antidiabetic medicine effect; monitor glucose carefully
• Mood changes — very rare at recommended doses; report any unusual mood disturbances to your doctor particularly if you have a history of bipolar disorder
• Changes in thyroid symptoms — report any new fatigue, weight changes, or temperature sensitivity if you have co-existing thyroid disease

Drug Interactions

Storage Instructions

• Store below 25°C in a cool, dry place
• Protect from moisture and direct sunlight
• Keep in original packaging until use
• Keep out of reach of children (بچوں کی پہنچ سے دور رکھیں)
• Do not use after the expiry date printed on the pack

Frequently Asked Questions (FAQs)

Q: Why does Inositolic Combi use the specific 40:1 ratio of Myo-Inositol to D-Chiro-Inositol?

The 40:1 ratio mirrors the physiological Myo-Inositol to D-Chiro-Inositol ratio found in healthy human plasma — clinical studies confirm this ratio produces the best combined outcomes for oocyte quality, menstrual regularity, androgen reduction, and insulin sensitivity; higher DCI proportions paradoxically impair egg quality by depleting follicular Myo-Inositol below the threshold needed for oocyte maturation.

Q: How long before I see improvements in my menstrual cycle regularity with Inositolic Combi?

Most women with PCOS notice improvements in menstrual cycle regularity within 3 to 6 months of consistent daily supplementation — hormonal and metabolic changes require sustained inositol availability to develop progressively; continue under your gynaecologist's monitoring and do not stop and restart inconsistently.

Q: Can Inositolic Combi be taken during pregnancy?

Folic Acid 400mcg is not only safe but essential during early pregnancy for neural tube defect prevention — inositol supplementation during pregnancy requires your obstetrician's specific guidance on appropriate dosing as the evidence base is still developing; always inform your obstetrician of all supplements you are taking.

Q: Can Inositolic Combi replace Metformin for PCOS?

Inositolic Combi is a nutritional supplement — not a pharmaceutical medicine — and cannot replace medically prescribed Metformin; however inositol and Metformin have complementary mechanisms and are frequently used together under gynaecologist and endocrinologist supervision for enhanced PCOS management; never stop or reduce Metformin without your doctor's explicit advice.

Medical Disclaimer: Inositolic Combi is a dietary supplement — not a pharmaceutical medicine. It is not intended to diagnose, treat, cure, or prevent any disease including PCOS or infertility. These statements describe the nutritional roles of ingredients based on scientific literature and have not been evaluated as pharmaceutical drug claims. PCOS is a complex medical condition requiring diagnosis and ongoing management by a qualified gynaecologist or endocrinologist — nutritional supplementation supports but does not replace medical treatment.